GWQ SERVICEPLUS AG has floated a tender for Contract notice: Pharmaceutical products. The project location is Germany and the tender is closing on 10 Dec 2020. The tender notice number is 546452-2019, while the TOT Ref Number is 38147131. Bidders can have further information about the Tender and can request the complete Tender document by Registering on the site.

Expired Tender

Procurement Summary

Country : Germany

Summary : Contract notice: Pharmaceutical products

Deadline : 10 Dec 2020

Other Information

Notice Type : Tender

TOT Ref.No.: 38147131

Document Ref. No. : 546452-2019

Competition : ICB

Financier : Self Financed

Purchaser Ownership : -

Tender Value : Refer Document

Purchaser's Detail

Purchaser : GWQ SERVICEPLUS AG
Office Name: GWQ ServicePlus AG
Address: GWQ ServicePlus AG, Tersteegenstraße 28, 40474 Düsseldorf, handelnd für die unter VI 2.) näher genannten Gesetzlichen Krankenkassen
Town: Düsseldorf
Postal Code: 40474


Phone: +49 211758498-0
Fax: +49 211758498-48
Germany
Email :bieteranfrage@gwq-serviceplus.de
URL :http://www.gwq-serviceplus.de

Tender Details

Object of the contract
Pharmaceutical products

Description: Contract notice: Pharmaceutical products

Authority Type: Body governed by public law
Contact Nature: Supplies
Procedure: Open procedure
Document: Contract notice
Regulation: European Union
Award criteria: Lowest price
CPV code: 33600000, 33600000
CPV Description: Pharmaceutical products.

Conclusion of a non-exclusive discount agreement according to - 130a Abs. 8 SGB V on finished medicinal products (here: Diclofenac ATR; ATC S01BC03)

- 130a Abs. 8 SGB V allows the health insurance (KK) and pharmaceutical companies, framework discounts exclude the medicinal products to be released at the expense of the statutory KK.

GWQ ServicePlus AG intends to provide non-exclUsual discount agreements according to - 130a Abs. 8 SGB V on the o. a. To close active ingredient with contract start on 1.1.2020. This contract can at any time of the contract period all interested companies to join the same conditions (approval model). The GWQ assumes that this procedure is due to a lack of selection decision and thus the non-discriminatory Zof all pharmaceutical companies does not fall within the scope of antitrust law. The contract documents, the participating health insurance companies and their sales as well as the dates for the notification of the contract can be viewed and downloaded on the allocation portal of GWQ ServicePlus AG under http://vergabeportal.gwq-serviceplus.de. Until the start of the exclusive contractThis transitional agreement is open to all market participants for accession.

Upon receipt of the signed contract / declarations and evidence as of 10.12.2019, a first notification can be made by 1.1.2020.

The following documents must be submitted: - signed contract in duplicate,

- Proof of the drug approval by means of an excerpt from the o- Part of the AMIS database,

- signed self-declaration (Annex 3),

- PZN list (Annex 4).

GWQ acts on behalf of the following statutory health insurances:

Atlas BKK ahlmann

Audi BKK

BAHN-BKK

Bertelsmann BKK

Health Insurance Fund of MTU Friedrichshafen GmbH

Health Insurance Company Herford Minden Ravensberg

BKK Aesculap

BKK Akzo Nobel Bavaria

BKK BPW Bergische Axis KG

BKK Deutsche BAnk AG

BKK Diakonia

BKK_DuerkoppEnerger

BKK Faber-Castell & Partner

Company Health Insurance Company firmus

BKK Freudenberg

BKK Groz-Beckert

BKK KBA

Krones BKK

BKK Black Forest Baar Heuberg

BKK Voralb Heller * Index * Leuze

BMW BKK

Daimler BKK

THE BERGISCHE KRANKENKASSE

The Schwenninger Health Insurance

Home Health Insurance

HEK - Hanseatic Health Insurance

IKK Brandenburg and Berlin

IKK healthy plus

IKK North

IKK Suedwest

MERCK BKK

Salus BKK

SBK Siemens Company Health Insurance Fund

SECURVITA BKK

SKD BKK

Suedzucker BKK

Wieland BKK


Internet address (URL): http://www.gwq-serviceplus.de

Documents

 Tender Notice